Impact of the Clinical Trials Act 2018 on clinical trial activity in Japan from 2018 to 2020: a retrospective database study using new and conventional Japanese registries

OBJECTIVE: To clarify the impact of Japan’s Clinical Trials Act (CTA), which was enacted in April 2018, on subsequent clinical trial activity through an analysis of Japanese registry data. DESIGN: Retrospective database study. SETTING: We extracted information on clinical intervention studies regist...

Descripción completa

Detalles Bibliográficos
Autores principales: Taruno, Hiroyuki, Oba, Mari S, Takizawa, Osamu, Kikuchi, Kayoko, Matsui, Kazuaki, Shikano, Mayumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297204/
https://www.ncbi.nlm.nih.gov/pubmed/35851007
http://dx.doi.org/10.1136/bmjopen-2021-059092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297204/
https://www.ncbi.nlm.nih.gov/pubmed/35851007
http://dx.doi.org/10.1136/bmjopen-2021-059092

Ejemplares similares